HISTOLOGICAL EFFECTS OF PROGESTINS ON HYPERPLASIA AND CARCINOMA IN SITU OF THE ENDOMETRIUM--FURTHER OBSERVATIONS.
D002278:Carcinoma in Situ; D004358:Drug Therapy; D004714:Endometrial Hyperplasia; D004717:Endometrium; D005260:Female; D005853:Geriatrics; D006801:Humans; D006908:Hydroxyprogesterones; D006965:Hyperplasia; D007044:Hysterectomy; D008525:Medroxyprogesterone; D008593:Menopause; D008656:Mestranol; D009369:Neoplasms / Q000628:therapy*; D009640:Norethindrone; D009641:Norethynodrel; D010336:Pathology; D011372:Progestins; D014594:Uterine Neoplasms
D006908:Hydroxyprogesterones; D011372:Progestins; D009641:Norethynodrel; D008656:Mestranol; D008525:Medroxyprogesterone; D009640:Norethindrone
DRUG THERAPY; ENDOMETRIAL HYPERPLASIA; GERIATRICS; HYDROXYPROGESTERONE; HYSTERECTOMY; MEDROXYPROGESTERONE; MENOPAUSE; MESTRANOL; NEOPLASM THERAPY; NORETHINDRONE; NORETHYNODREL; PATHOLOGY; PROGESTATIONAL HORMONES; UTERINE NEOPLASMS